Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Howells

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
British Journal of Cancer|August 1, 1988
Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazineI J Stratford, G E Adams, J Godden, et al.
Oncogene|August 12, 1999
Inhibition of MT-450 rat mammary tumour growth by antibodies recognising subtypes of blood group antigen BJ P Sleeman, U Kim, J LePendu, et al.
British Journal of Cancer|June 1, 1993
Flavone acetic acid (FAA) with recombinant interleukin-2 (rIL-2) in advanced malignant melanoma. IV: Pharmacokinetics and toxicity of flavone acetic acid and its metabolitesM R Stratford, G J Rustin, M F Dennis, et al.
The Journal of Cell Biology|November 1, 1994
Degeneration of neural cells in the central nervous system of mice deficient in the gene for the adhesion molecule on Glia, the beta 2 subunit of murine Na,K-ATPaseJ P Magyar, U Bartsch, Z Q Wang, et al.
Palliative Medicine|September 23, 1998
Development of an aromatherapy service at a Cancer CentreS M Kite, E J Maher, K Anderson, et al.
Journal of Cell Science|June 23, 2000
CD44 expression and regulation during mammary gland development and functionL Hebbard, A Steffen, V Zawadzki, et al.
FEBS Letters|June 5, 1989
Induction of tumour hypoxia by a vasoactive agent. A combined NMR and radiobiological studyJ F Dunn, S Frostick, G E Adams, et al.
The British Journal of Surgery|July 7, 2017
Systematic review of management of chronic pain after surgeryV Wylde, J Dennis, A D Beswick, et al.
Oncogene|June 26, 2001
Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acidT Ahrens, J P Sleeman, C M Schempp, et al.
Lancet (London, England)|August 24, 1991
Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapyD B Smith, E S Newlands, G J Rustin, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|August 1, 1988
Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazineI J Stratford, G E Adams, J Godden, et al.
Oncogene|August 12, 1999
Inhibition of MT-450 rat mammary tumour growth by antibodies recognising subtypes of blood group antigen BJ P Sleeman, U Kim, J LePendu, et al.
British Journal of Cancer|June 1, 1993
Flavone acetic acid (FAA) with recombinant interleukin-2 (rIL-2) in advanced malignant melanoma. IV: Pharmacokinetics and toxicity of flavone acetic acid and its metabolitesM R Stratford, G J Rustin, M F Dennis, et al.
The Journal of Cell Biology|November 1, 1994
Degeneration of neural cells in the central nervous system of mice deficient in the gene for the adhesion molecule on Glia, the beta 2 subunit of murine Na,K-ATPaseJ P Magyar, U Bartsch, Z Q Wang, et al.
Palliative Medicine|September 23, 1998
Development of an aromatherapy service at a Cancer CentreS M Kite, E J Maher, K Anderson, et al.
Journal of Cell Science|June 23, 2000
CD44 expression and regulation during mammary gland development and functionL Hebbard, A Steffen, V Zawadzki, et al.
FEBS Letters|June 5, 1989
Induction of tumour hypoxia by a vasoactive agent. A combined NMR and radiobiological studyJ F Dunn, S Frostick, G E Adams, et al.
The British Journal of Surgery|July 7, 2017
Systematic review of management of chronic pain after surgeryV Wylde, J Dennis, A D Beswick, et al.
Oncogene|June 26, 2001
Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acidT Ahrens, J P Sleeman, C M Schempp, et al.
Lancet (London, England)|August 24, 1991
Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapyD B Smith, E S Newlands, G J Rustin, et al.
Pageof 3